ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

WINT Windtree Therapeutics Inc

5,10
0,035 (0,69%)
Vor Marktöffnung
Zuletzt aktualisiert: 12:03:21
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Windtree Therapeutics Inc WINT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,035 0,69% 5,10 12:03:21
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
5,065
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
18.4.202414:00GLOBEWindtree Therapeutics Announces Reverse Stock Split
17.4.202414:00GLOBEWindtree Therapeutics Reports Fourth Quarter and Year-End..
08.4.202422:48GLOBEWindtree Acquires Early-Stage, Novel Oncology Platform and..
16.2.202423:07EDGAR2Form 8-K - Current report
14.2.202423:23EDGAR2Form S-3 - Registration statement under Securities Act of..
14.2.202422:30EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202402:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202422:40EDGAR2Form PRE 14A - Other preliminary proxy statements
01.2.202423:26EDGAR2Form SC 13G - Statement of acquisition of beneficial..
01.2.202414:00GLOBEWindtree Renews Agreement with Chang Gung University for..
31.1.202414:40IHNWWindtree Therapeutics Announces Engagement of Strategic..
31.1.202414:00EDGAR2Form 8-K - Current report
31.1.202414:00GLOBEWindtree Therapeutics Announces Engagement of Strategic..
25.1.202415:04IHNWWindtree Eliminates $15 Million Contingent Liability to..
25.1.202414:34EDGAR2Form 8-K - Current report
25.1.202414:30GLOBEWindtree Eliminates $15 Million Contingent Liability to..
22.1.202422:45EDGAR2Form 8-K - Current report
17.1.202414:00GLOBEWindtree Therapeutics Announces License Agreement with Lee’s..
17.1.202413:56EDGAR2Form 8-K - Current report
16.1.202422:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02.1.202422:05GLOBEWindtree Therapeutics Announces Reduction In Arrythmias In A..
18.12.202314:00GLOBEWindtree Therapeutics Announces the Start of Patient Dosing..
16.11.202314:00GLOBEWindtree Therapeutics Announces Issuance of New Pure SERCA2a..
13.11.202317:41EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09.11.202322:21EDGAR2Form 8-K - Current report
09.11.202322:15GLOBEWindtree Therapeutics Reports Third Quarter 2023 Financial..
09.11.202322:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09.11.202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202314:00GLOBEWindtree to Present at the Sidoti Micro Cap Conference on..
12.10.202313:30GLOBEWindtree to Present at the ThinkEquity Conference on October..
10.10.202313:30GLOBEWindtree to Participate in the Lytham Partners Fall 2023..
03.10.202314:00GLOBEWindtree to Present at the Dawson James Small Cap Growth..
28.9.202313:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.9.202313:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.9.202314:48EDGAR2Form 8-K - Current report
21.9.202315:35GLOBEDawson James Securities Announces October Date for 8th..
06.9.202301:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
30.8.202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.8.202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.8.202322:15EDGAR2Form 8-K - Current report
26.8.202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.8.202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.8.202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.8.202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.8.202300:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.8.202314:00GLOBEWindtree Announces Issuance of Composition of Matter Patent..
16.8.202323:19EDGAR2Form 8-K - Current report
07.8.202322:05GLOBEWindtree Therapeutics Reports Second Quarter 2023 Financial..
07.8.202322:02EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock